Amwell Co-Founder Roy Schoenberg Becomes Executive Vice Chairman of the Board
13 Juin 2024 - 2:05PM
Amwell® (NYSE: AMWL), a leader in digital care, today
announced that co-founder and visionary healthcare technology
leader Roy Schoenberg, M.D., M.P.H., is transitioning from his role
as president and co-CEO to become Executive Vice Chairman of
Amwell’s Board of Directors. Ido Schoenberg, M.D., will assume the
role of sole Chief Executive Officer of Amwell.
Since co-founding Amwell in 2006, Roy Schoenberg has been a
driving force behind the nation’s embrace of digital healthcare.
His vision of democratizing the availability and distribution of
healthcare, using modern technology, laid the foundation for how
patients and clinicians experience digital care. His relentless
pursuit to advance our view of the possible helped the industry
welcome new efficiencies, embrace care automation, healthcare AI
and related technologies, and further elevate how and where
patients can be cared for. When the COVID-19 pandemic disrupted
in-person care, he worked tirelessly with payers, providers and
regulators to ensure the industry could keep its obligation to its
patients, using technology. While doing so, Roy Schoenberg helped
grow the Amwell platform to reach over 100,000 active clinicians
and many millions of patients annually across the globe. As the
world recovered from the pandemic, he began to architect a
next-generation platform – the Amwell Converge™ platform – to
support a fast-evolving world of expectations where care is
rendered as a balance of in-person and digital experiences.
Bringing healthcare to patients has been Roy Schoenberg’s mission
and continues to be Amwell’s.
“The time is now to take the next step in our mission. Our
unique opportunity to realize the immense value in new Amwell
technology – while achieving critical operational and clinical
goals – is both timely and exciting. I am confident in our talented
leadership team and will continue to support them in our journey to
digitally reimagine healthcare,” said Roy Schoenberg, newly
appointed Amwell Executive Vice Chairman.
“This transition represents a natural evolution for our company
as we shift from a period of intense R&D investment to an
operational focus aimed at achieving greater efficiencies,
optimizing cash flow and delivering profitable growth while
maintaining our dedication to enabling our clients’ aspirations,”
said Ido Schoenberg. “Roy’s vision, leadership and unwavering
dedication has resulted in the creation of a powerful, innovative
enterprise technology that has helped establish Amwell as a global
provider of world-class software that enables hybrid care
delivery.”
Angela Vogen
Amwell
press@amwell.com
Sue Dooley
415-602-9167
American Well (NYSE:AMWL)
Graphique Historique de l'Action
De Sept 2024 à Oct 2024
American Well (NYSE:AMWL)
Graphique Historique de l'Action
De Oct 2023 à Oct 2024